Comparison of efficacy of intravitreal ranibizumab between non-vitrectomized and vitrectomized eyes with diabetic macular edema

被引：0
作者：
Yen-Yi Chen
Pei-Ying Chen
Fang-Ting Chen
Yun-Ju Chen
Jia-Kang Wang
机构：
[1] Far Eastern Memorial Hospital,Department of Ophthalmology
[2] Fu Jen Catholic University,Department of Medicine
[3] National Taiwan University,Department of Medicine
[4] National Yang Ming University,Department of Medicine
[5] Yuan Ze University,Department of Electrical Engineering
[6] Oriental Institute of Technology,Department of Healthcare Administration and Department of Nursing
来源：
International Ophthalmology | 2018年 / 38卷
关键词：
Intravitreal injection; Diabetic macular edema; Ranibizumab; Vitrectomized eyes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：293 / 299
页数：6
相关论文
共 50 条
  • [21] Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
    Coelho, Joao
    Malheiro, Luisa
    Beirao, Joao Melo
    Meireles, Angelina
    Pessoa, Bernardete
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 1751 - 1759
  • [22] One-Month Outcomes of Intravitreal Anti-VEGF vs. Dexamethasone Implant in the Treatment of Diabetic Macular Edema in Vitrectomized Eyes
    Liang, Youling
    Yan, Bin
    Xie, Manyun
    Meng, Zhishang
    Ma, Jiayue
    Ma, Bosheng
    Luo, Jing
    FRONTIERS IN MEDICINE, 2022, 9
  • [23] Comparison of Modified Grid Laser & Intravitreal Ranibizumab, and Mild Macular Laser & Intravitreal Ranibizumab in the Treatment of Diabetic Macular Edema
    Guzey, Mustafa
    Adibelli, Fatih Mehmet
    Altun, Gonul
    OPHTHALMOLOGICA, 2014, 232 : 14 - 15
  • [24] Intravitreal Tissue Plasminogen Activator Injection for Treatment-Resistant Diabetic Macular Edema of the Vitrectomized Eye
    Aoki, Ren
    Hatano, Makoto
    Higashijima, Fumiaki
    Yoshimoto, Takuya
    Mikuni, Masanori
    Ogata, Tadahiko
    Kobayashi, Yuka
    Wakuta, Makiko
    Kimura, Kazuhiro
    CASE REPORTS IN OPHTHALMOLOGY, 2021, 12 (03): : 841 - 847
  • [25] Treatment of macular edema in diabetic retinopathy: comparison of the efficacy of intravitreal bevacizumab and ranibizumab injections
    Ekinci, Metin
    Ceylan, Erdinc
    Cakici, Ozgur
    Tanyildiz, Burak
    Olcaysu, Okan
    Cagatay, Halil Huseyin
    EXPERT REVIEW OF OPHTHALMOLOGY, 2014, 9 (02) : 139 - 143
  • [26] Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
    Gabr, Ahmed F.
    Kamel, Marian F.
    Elbarawy, Ahmed A.
    INTERNATIONAL OPHTHALMOLOGY, 2023, 43 (09) : 3219 - 3226
  • [27] Early Retinal Vascular Caliper Changes After Intravitreal Ranibizumab in Eyes with Diabetic Macular Edema
    Aslankurt, Murat
    Kurt, Muhammet Mustafa
    Cekic, Osman
    Erden, Burak
    Akpolat, Cetin
    Elcioglu, Mustafa
    OPHTHALMOLOGICA, 2014, 232 : 63 - 63
  • [28] Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
    Ahmed F. Gabr
    Marian F. Kamel
    Ahmed A. Elbarawy
    International Ophthalmology, 2023, 43 : 3219 - 3226
  • [29] Effect of Macular Ischemia on Intravitreal Ranibizumab Treatment for Diabetic Macular Edema
    Douvali, Maria
    Chatziralli, Irini P.
    Theodossiadis, Panagiotis G.
    Chatzistefanou, Klio I.
    Giannakaki, Emmanouella
    Rouvas, Alexandros A.
    OPHTHALMOLOGICA, 2014, 232 (03) : 136 - 143
  • [30] A New Approach for Diabetic Macular Edema Treatment: Review of Clinical Practice Results with 0.19 mg Fluocinolone Acetonide Intravitreal Implant Including Vitrectomized Eyes
    Raquel Estebainha
    Raquel Goldhardt
    Manuel Falcão
    Current Ophthalmology Reports, 2020, 8 : 1 - 10
12345